Drugs for Lynch Syndrome (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):
(show top 50)
(show all 74)
# |
|
Name |
Status |
Phase |
Clinical Trials |
Cas Number |
PubChem Id |
1 |
|
Bevacizumab |
Approved, Investigational |
Phase 3,Phase 1 |
|
216974-75-3 |
|
Synonyms:
216974-75-3
antiVEGF
anti-VEGF monoclonal antibody
Avastin
Avastin (TN)
bevacizumab
|
Bevacizumab
Bevacizumab (genetical recombination)
Bevacizumab (genetical recombination) (JAN)
bevacizumab-awwb
D06409
R-435
|
|
2 |
|
Levonorgestrel |
Approved, Investigational |
Phase 3,Phase 2 |
|
797-63-7, 17489-40-6 |
13109
|
Synonyms:
(-)-13-Ethyl-17-hydroxy-18,19-dinor-17alpha-pregn-4-en-20-yn-3-one
(-)-Norgestrel
(8R,9S,10R,13S,14S,17R)-13-ethyl-17-ethynyl-17-hydroxy- 1,2,6,7,8,9,10,11,12,13,14,15,16, 17- tetradecahydrocyclopenta[a] phenanthren-3-one
)-Norgestrel
121714-72-5
13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE
13-Ehyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one
13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one
13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one
13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one
17-alpha-Ethinyl-13-beta-ethyl-17-beta-hydroxy-4-estren-3-one
17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-13-ethyl-19-nortestosterone
17-alpha-Ethynyl-13-ethyl-19-nortestosterone
17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one
17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17alpha-Ethynyl-18-homo-19-nortestosterone
17alpha-Ethynyl-18-homo-19-nor-testosterone
17-Ethynyl-18-methyl-19-nortestosterone
18,19-Dinor-4-pregnen-20-yn-3-one
18-Methyl-17-alpha-ethynyl-19-nortestosterone
18-Methylnorethisterone
4222-79-1
6533-00-2
72-HOURS
797-62-6
797-63-7
AC1L211U
AC1Q6OEV
alpha-Norgestrel
BAY 86-5028
BAY86-5028
BIDD:PXR0194
Bio-0595
BPBio1_000932
BRD-K35189033-001-03-0
BRN 2391114
BSPBio_000846
C08149
C08153
Capronor
CCRIS 6525
CCRIS 9033
CHEBI:44593
CHEBI:6443
CHEMBL1389
CID13109
component of Lo/ovral
CPD000059117
D(−
d(-)-Norgestrel
D(-)-Norgestrel
D-(-)-Norgestrel
D00950
D00954
DB00367
DB00506
dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone
dl-Norgestrel
D-Norgestrel
E-Gen-C
EINECS 212-349-8
EINECS 229-433-5
FH 122-A
Follistrel
HMS1570K08
HMS2051M08
HMS2090O06
HSDB 3595
HSDB 6483
Jadelle
Ld norgestrel
LD norgestrel [French]
Levlen
Levlen ED
Levonelle
Levonelle, D-Norgestrel, Levonova, Levonorgestrel
Levonorgestrel
Lévonorgestrel
Levonorgestrel (JAN/USP/INN)
Levonorgestrel [USAN:INN:BAN]
Levonorgestrel implants
Levonorgestrelum
Levonorgestrelum [INN-Latin]
Levonova
Levora-21
Levora-28
LMST02030119
LO/Ovral
|
Logynon ED
LS-62083
LS-62084
Methylnorethindrone
Microgest ED
Microgyn
Microgynon 21
Microgynon 28
Microgynon 30 ED
Microgynon CD
Microlut
Microlution
Microluton
Microval
Minivlar 30
Mirena
Mirena (TN)
MLS000069491
MLS000759484
MLS001074069
MolPort-002-510-453
Monofeme 28
Monovar
N2260_FLUKA
N2260_SIGMA
NCGC00159349-02
NCGC00159349-03
Neogest
Neogynon 21
Nordet
Nordette 21
Nordette 28
Norgeston
norgestrel
Norgestrel (JP15/USP/INN)
Norgestrel [Progestins]
Norgestrel [USAN:BAN:INN:JAN]
Norgestrel [USAN:INN:BAN:JAN]
Norgestrel-(-)-D
Norgestrelum
Norgestrelum [INN-Latin]
NorLevo
NORPLANT
Norplant (TN)
Norplant 2
Norplant II
Norplant System in Plastic Container
Norplant-2
NSC744007
Ovoplex 30-150
Ovral-Lo
Ovranette
Ovrette
Ovrette (TN)
Plan B
Postinor
Postinor-2
Prestwick_109
Prestwick0_000773
Prestwick1_000773
Prestwick2_000773
Prestwick3_000773
Preven
Rigevidon 21+7
S1727_Selleck
SAM001246694
SH 70850
SH 850
SMR000059117
SMR000653526
SOH-075
SPBio_002785
Stediril 30
Tetragynon
Triagynon
Triciclor
Trifeme 28
Trigoa
Tri-Levlen 21
Trinordiol 21
Trinordiol 28
Triphasil 21
Triphasil 28
Triquilar ED
Trivora
UNII-3J8Q1747Z2
UNII-5W7SIA7YZW
Wy 3707
Wy-3707
Wy-5104
ZINC03814395
|
|
3 |
|
Aspirin |
Approved, Vet_approved |
Phase 3 |
|
50-78-2 |
2244
|
Synonyms:
11126-35-5
11126-37-7
1oxr
2-(Acetyloxy)benzoate
2-(Acetyloxy)benzoic acid
2349-94-2
26914-13-6
2-Acetoxybenzenecarboxylic acid
2-Acetoxybenzoate
2-Acetoxybenzoic acid
2-Carboxyphenyl acetate
50-78-2
8-hour Bayer
98201-60-6
A 5376
A.S.A
A.S.A.
A.S.A. empirin
A.S.A. Empirin
A2093_SIGMA
A3160_SIGMA
A5376_SIGMA
A6810_SIGMA
AB1003266
AC 5230
AC1L1D8U
AC1Q1LA0
Acenterine
Acesal
Acetal
Acetard
Aceticyl
Acetilsalicilico
Acetilum acidulatum
Acetisal
Acetol
Acetonyl
Acetophen
Acetosal
Acetosalic acid
Acetosalin
Acetoxybenzoic acid
Acetylin
Acetylsal
Acetylsalicylate
Acetylsalicylic acid
ACETYLSALICYLIC ACID
Acetylsalicylsaeure
Acetylsalicylsaure
Acetylsalicylsäure
Acetylsalycilic acid
Acetyonyl
Acetysal
Acetysalicylic acid
acide 2-(acétyloxy)benzoïque
Acide acetylsalicylique
acide acétylsalicylique
Acido acetilsalicilico
ácido acetilsalicílico
Acido O-acetil-benzoico
Acidum acetylsalicylicum
Acimetten
Acisal
Acylpyrin
Adiro
AI3-02956
AIN
AKOS000118884
Aloxiprimum
ASA
Asacard
Asagran
Asatard
Ascoden-30
Aspalon
Aspec
Aspergum
Aspirdrops
aspirin
Aspirin
Aspirin (JP15/USP)
Aspirin [BAN:JAN]
Aspirina 03
Aspirine
Aspir-Mox
Asprin
Aspro
Aspro Clear
Asteric
Azetylsalizylsaeure
Azetylsalizylsäure
Bay-e-4465
Bayer
Bayer Aspirin 8 Hour
Bayer Buffered
Bayer Extra Strength Aspirin For Migraine Pain
Bayer Plus
Benaspir
Bialpirina
Bialpirinia
BIDD:GT0118
Bi-prin
BRN 0779271
Bufferin
C01405
Caprin
Cardioaspirin
Cardioaspirina
CCRIS 3243
Cemirit
CHEBI:15365
CHEMBL25
CID2244
Claradin
Clariprin
cMAP_000006
Colfarit
component of Midol
component of Synirin
Contrheuma retard
Coricidin
Crystar
D00109
D001241
DB00945
Decaten
Delgesic
Dispril
DivK1c_000555
Dolean pH 8
Duramax
Easprin
Easprin (TN)
ECM
Ecolen
Ecotrin
EINECS 200-064-1
Empirin
|
Empirin with Codeine
Endosprin
Endydol
Entericin
Enterophen
Enterosarein
Enterosarine
Entrophen
EU-0100038
Extren
Globentyl
Globoid
Helicon
HMS1920E13
HMS2090G03
HMS2091K13
HMS501L17
HSDB 652
I14-7505
IDI1_000555
Idragin
Istopirin
Kapsazal
KBio1_000555
KBio2_001725
KBio2_002271
KBio2_004293
KBio2_004839
KBio2_006861
KBio2_007407
KBio3_002149
KBio3_002751
KBioGR_000398
KBioGR_002271
KBioSS_001725
KBioSS_002272
Kyselina 2-acetoxybenzoova
Kyselina acetylsalicylova
Levius
Lopac0_000038
Lopac-A-5376
LS-143
Magnecyl
Measurin
Medisyl
Micristin
MLS001055329
MLS001066332
MLS001336045
MLS001336046
MolPort-000-871-622
NCGC00015067-01
NCGC00015067-04
NCGC00015067-09
NCGC00090977-01
NCGC00090977-02
NCGC00090977-03
NCGC00090977-04
NCGC00090977-05
NCGC00090977-06
NCGC00090977-07
nchem.859-comp6
NCI60_002222
Neuronika
NINDS_000555
Novid
NSC 27223
NSC27223
NSC406186
Nu-seals
Nu-seals aspirin
O-(Acetyloxy)benzoate
O-(Acetyloxy)benzoic acid
O-accetylsalicylic acid
O-Acetoxybenzoate
o-acetoxybenzoic acid
o-Acetoxybenzoic acid
O-Acetoxybenzoic acid
O-acetylsalicylic acid
O-Acetylsalicylic acid
o-carboxyphenyl acetate
o-Carboxyphenyl acetate
O-Carboxyphenyl acetate
Persistin
Pharmacin
Pirseal
PL-2200
Polopirin
Polopiryna
Premaspin
R16CO5Y76E [UNII]
Rheumin tabletten
Rheumintabletten
Rhodine
Rhonal
Ronal
S-211
Salacetin
Salcetogen
Saletin
salicylic acid acetate
Salicylic acid acetate
Salicylic acid, acetate
Salospir
SMR000059138
Solfrin
Solprin
Solprin acid
Solpyron
Solupsan
SP 189
SPBio_001838
Spectrum_001245
SPECTRUM1500130
Spectrum2_001899
Spectrum3_001295
Spectrum4_000099
Spectrum5_000740
Spira-Dine
St. Joseph
St. Joseph Aspirin for Adults
ST075414
Supac
Tasprin
Temperal
Toldex
Triaminicin
Triple-sal
UNII R16CO5Y76E
UNII=R16CO5Y76E
UNII-R16CO5Y76E
UNM-0000306102
Vanquish
WLN: QVR BOV1
Xaxa
XAXA
Yasta
ZORprin
|
|
4 |
|
Fluorouracil |
Approved |
Phase 3 |
|
51-21-8 |
3385
|
Synonyms:
1004-03-1
1-fluoro-1h-pyrimidine-2,4-dione
1upf
2,4-Dihydroxy-5-fluoropyrimidine
2,4-Dioxo-5-fluoropryimidine
2,4-Dioxo-5-fluoropyrimidine
47576_FLUKA
4921-97-5
5 Fluorouracil
5 Fluorouracil biosyn
5 FU Lederle
5 FU medac
5 HU Hexal
51-21-8
5-Faracil
5-Fluor-2,4(1H,3H)-pyrimidindion
5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]
5-Fluor-2,4-dihydroxypyrimidin
5-Fluor-2,4-dihydroxypyrimidin [Czech]
5-Fluor-2,4-pyrimidindiol
5-Fluor-2,4-pyrimidindiol [Czech]
5-Fluoracil
5-Fluoracil [German]
5-Fluoracyl
5-fluoro uracil
5-fluoro-1H-pyrimidine-2,4-dione
5-Fluoro-2,4(1H,3H)-pyrimidinedione
5-Fluoro-2,4-pyrimidinedione
5-Fluoropyrimidin-2,4-diol
5-fluoropyrimidine-2,4(1H,3H)-dione
5-Fluoropyrimidine-2,4-dione
5-fluorouracil
5-Fluorouracil
5-Fluorouracil-biosyn
5-Fluoruracil
5-Fluoruracil [German]
5-Fluracil
5-Ftouracyl
5FU
5-FU
5-FU (TN)
5-FU Lederle
5-FU medac
5-HU Hexal
79108-01-3
AC-11201
AC1L1FTE
AC1Q4N2X
AccuSite
Actino-Hermal
Adrucil
Adrucil (TN)
AI3-25297
AKOS000119162
AKOS003237897
Allergan Brand of Fluorouracil
Arumel
BB_NC-0576
biosyn Brand of Fluorouracil
BSPBio_002048
C07649
C4H3FN2O2
Carac
Carac (TN)
Carzonal
CCRIS 2582
CHEBI:46345
CHEMBL185
CID3385
Cinco FU
CPD000038082
CPD0-1327
CSP Brand of Fluorouracil
Cytosafe
D005472
D00584
Dakota Brand of Fluorouracil
Dakota, Fluorouracile
DB00544
Dermatech Brand of Fluorouracil
Dermik Brand of Fluorouracil
DivK1c_000054
Effluderm
Effluderm (free base)
Efudex
Efudix
Efurix
EINECS 200-085-6
EU-0100536
F 6627
F0151
F6627_SIGMA
F8423_SIGMA
Ferrer Brand of Fluorouracil
Fiverocil
Fluoro Uracil
Fluoro Uracile ICN
Fluoroblastin
Fluoroplex
Fluoroplex (TN)
fluorouracil
Fluorouracil
Fluorouracil (JP15/USP/INN)
Fluorouracil [USAN:INN:BAN:JAN]
Fluorouracil GRY
Fluorouracil Mononitrate
Fluorouracil Monopotassium Salt
Fluorouracil Monosodium Salt
Fluorouracil Potassium Salt
Fluorouracil Teva Brand
Fluorouracile
Fluoro-uracile
Fluorouracile [DCIT]
Fluorouracile Dakota
|
Fluoro-Uracile ICN
Fluorouracil-GRY
Fluorouracilo
Fluoro-uracilo
Fluorouracilo [INN-Spanish]
Fluorouracilo Ferrer Far
Fluorouracilum
Fluorouracilum [INN-Latin]
Fluoruracil
Fluouracil
Flurablastin
Fluracedyl
Fluracil
Fluracilum
Fluri
Fluril
Fluro Uracil
Fluroblastin
Flurodex
Flurouracil
Flurox
FT-0082524
Ftoruracil
FU
Gry Brand of Fluorouracil
Haemato Brand of Fluorouracil
Haemato fu
Haemato-fu
Hexal Brand of Fluorouracil
HMS1920O18
HMS2090I04
HMS2091F19
HMS500C16
HSDB 3228
I07-0022
ICN Brand of Fluorouracil
IDI1_000054
IN1335
inhibits thymilidate synthetase
KBio1_000054
KBio2_001321
KBio2_003889
KBio2_006457
KBio3_001268
KBioGR_001253
KBioSS_001321
Kecimeton
Lopac0_000536
Lopac-F-6627
LS-153
medac Brand of Fluorouracil
MLS000069498
MLS002415705
MolPort-000-156-102
MolPort-003-990-447
MolPort-004-758-143
MolPort-004-758-144
MolPort-005-861-486
NCGC00015442-01
NCGC00015442-03
NCGC00015442-10
NCGC00091349-01
NCGC00091349-02
NCGC00091349-03
NCGC00091349-04
NCGC00091349-05
NCGC00091349-07
NCGC00091349-08
nchembio.90-comp3
nchembio809-comp6
NCI60_001652
Neocorp Brand of Fluorouracil
Neofluor
NINDS_000054
NSC 19893
NSC19893
NSC-19893
Onkofluor
Onkoworks Brand of Fluorouracil
Phthoruracil
Phtoruracil
Queroplex
Ribofluor
ribosepharm Brand of Fluorouracil
Riemser Brand of Fluorouracil
Ro 2-9757
Ro-2-9757
Roche Brand of Fluorouracil
S1209_Selleck
SAM002264615
SMR000038082
SPBio_000291
Spectrum_000841
SPECTRUM1500305
Spectrum2_000076
Spectrum3_000434
Spectrum4_000557
Spectrum5_000718
STK297802
T5233394
tetratogen
Teva Brand of Fluorouracil
Timazin
TL8006093
U 8953
U-8953
Ulup
UNII-U3P01618RT
UPCMLD-DP130
UPCMLD-DP130:001
URF
WLN: T6MVMVJ EF
ZINC00897110
|
|
5 |
|
Levoleucovorin |
Approved, Investigational |
Phase 3 |
|
68538-85-2 |
|
Synonyms:
(6S)-5-Formyl-5,6,7,8-tetrahydrofolic acid
(6S)-5-formyltetrahydrofolic acid
(6S)-Folinic acid
(6S)-Leucovorin
(S)-Leucovorin
|
Citrovorum factor
Levofolene
Levofolinic acid
L-Folinic acid
N-[4-({[(6S)-2-amino-5-formyl-4-oxo-1,4,5,6,7,8-hexahydropteridin-6-yl]methyl}amino)benzoyl]-L-glutamic acid
|
|
6 |
|
Oxaliplatin |
Approved, Investigational |
Phase 3 |
|
61825-94-3 |
43805
6857599
5310940
9887054
|
Synonyms:
CHEMBL1201055
CID9887054
D01790
DACPLAT
Diaminocyclohexane Oxalatoplatinum
Eloxatin
Eloxatin (TN)
Elplat
Foloxatine
L-OHP
Oxalatoplatin
Oxalatoplatinum
|
oxaliplatin
Oxaliplatin (JAN/USAN/INN)
Oxaliplatin [Usan:Inn:Ban]
oxaliplatine
oxaliplatino
Oxaliplatino [Spanish]
oxaliplatinum
Oxaliplatinum [Latin]
Oxaloplatine [French]
Oxaloplatino [Spanish]
Transplatin
|
|
7 |
|
Loperamide |
Approved |
Phase 3 |
|
53179-11-6 |
3955
|
Synonyms:
2-methoxyethyl1-methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate
34552-83-5 (mono-hydrochloride)
4-(4-Chlorophenyl)-N,N-dimethyl-.alpha.,.alpha.-diphenyl-4-hydroxy-1-piperidinebutanamide
4-(4-Chlorophenyl)-N,N-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide
4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide
5-21-02-00379 (Beilstein Handbook Reference)
53179-11-6
AB00053697
AC1L1H38
AKOS000573892
Apo-Loperamide
BAS 01889668
Bio1_000082
Bio1_000571
Bio1_001060
Bio2_000101
Bio2_000581
BPBio1_000274
BRD-K61250553-001-02-9
BRD-K61250553-003-05-8
BRN 1558273
BSPBio_000248
BSPBio_001381
BSPBio_002769
C07080
C29H33ClN2O2
CAS-34552-83-5
CBiol_001796
CHEBI:162259
CHEBI:6532
CHEMBL841
CID3955
D08144
DB00836
Diamide (TN)
Diarr-Eze
DivK1c_000215
EINECS 258-416-5
HMS1791F03
HMS1989F03
HMS2089C13
IDI1_000215
IDI1_033851
Imodium A-D
Imodium A-D Caplets
Ioperamide
Kaopectate II
KBio1_000215
KBio2_000101
KBio2_000854
KBio2_002669
KBio2_003422
KBio2_005237
KBio2_005990
KBio3_000201
|
KBio3_000202
KBio3_001989
KBioGR_000101
KBioGR_001685
KBioSS_000101
KBioSS_000854
L000709
Lopac0_000708
Lopac-L-4762
Loperacap
Loperamid
Loperamida
Loperamida [INN-Spanish]
loperamide
Lopéramide
Loperamide (INN)
Loperamide [INN:BAN]
Loperamide hydrochloride
Loperamide Monohydrochloride
Loperamidum
Loperamidum [INN-Latin]
LS-114352
Maalox Anti-Diarrheal
MolPort-001-969-016
NCGC00015608-01
NCGC00015608-08
NCGC00016828-01
NCGC00024818-01
NCGC00024818-02
NCGC00024818-03
NCGC00024818-04
NCGC00024818-05
nchembio.559-comp8
nchembio.79-comp7
NINDS_000215
Nu-Loperamide
Oprea1_109220
Pepto Diarrhea Control
PMS-Loperamide
Prestwick0_000144
Prestwick1_000144
Prestwick2_000144
Prestwick3_000144
R-18553
Rho-Loperamide
SPBio_001816
SPBio_002187
Spectrum_000374
Spectrum2_001738
Spectrum3_001015
Spectrum4_001143
Spectrum5_001374
ST095179
Tocris-0840
UNII-6X9OC3H4II
|
|
8 |
|
Folic Acid |
Approved, Nutraceutical, Vet_approved |
Phase 3 |
|
59-30-3 |
6037
|
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
AI3-26387
AKOS000503224
Antianemia factor
Apo-Folic
ARONIS014410
BIDD:ER0563
BIDD:GT0641
BIF0608
bmse000299
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
Facid
Factor U
FOL
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
folic acid
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
|
Folsaeure
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
Incafolic
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
Liver Lactobacillus casei factor
LS-2157
Millafol
Mission prenatal
Mittafol
MLS001304016
MLS001335861
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
nchembio.108-comp10
Nifolin
Nifolin [Denmark]
NINDS_000494
Novofolacid
Novofolacid [Canada]
N-Pteroyl-L-glutamic acid
NSC 3073
PGA
PGA (VAN)
Prestwick_230
Prestwick3_000627
PteGlu
Pteroylglutamate
Pteroylglutamic acid
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
Serum Folate Level
SMP2_000137
SMR000471860
SPBio_001357
Spectrum_001381
SPECTRUM1502020
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
|
|
9 |
|
leucovorin |
Approved, Nutraceutical |
Phase 3 |
|
58-05-9 |
143
6006
|
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-formyltetrahydrofolic acid
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
folinate
Folinate
Folinic acid
Folinic acid calcium salt
|
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
L-leucovorin
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
N5-Formyl-THF
Welcovorin
Wellcovorin
|
|
10 |
|
Analgesics |
|
Phase 3,Phase 2,Phase 1 |
|
|
|
11 |
|
Analgesics, Non-Narcotic |
|
Phase 3,Phase 2,Phase 1 |
|
|
|
12 |
|
Anti-Inflammatory Agents |
|
Phase 3,Phase 2,Phase 1 |
|
|
|
13 |
|
Anti-Inflammatory Agents, Non-Steroidal |
|
Phase 3,Phase 2,Phase 1 |
|
|
|
14 |
|
Antirheumatic Agents |
|
Phase 3,Phase 2,Phase 1 |
|
|
|
15 |
|
Cyclooxygenase Inhibitors |
|
Phase 3,Phase 1 |
|
|
|
16 |
|
Peripheral Nervous System Agents |
|
Phase 3,Phase 2,Phase 1 |
|
|
|
17 |
|
Angiogenesis Inhibitors |
|
Phase 3,Phase 1 |
|
|
|
18 |
|
Angiogenesis Modulating Agents |
|
Phase 3,Phase 1 |
|
|
|
19 |
|
Endothelial Growth Factors |
|
Phase 3,Phase 1 |
|
|
|
20 |
|
Mitogens |
|
Phase 3,Phase 1 |
|
|
|
21 |
|
Contraceptive Agents |
|
Phase 3,Phase 2 |
|
|
|
22 |
|
Contraceptives, Oral |
|
Phase 3,Phase 2 |
|
|
|
23 |
|
Acetylsalicylic acid lysinate |
|
Phase 3 |
|
|
|
24 |
|
Antipyretics |
|
Phase 3 |
|
|
|
25 |
|
Fibrinolytic Agents |
|
Phase 3 |
|
|
|
26 |
|
Platelet Aggregation Inhibitors |
|
Phase 3 |
|
|
|
27 |
|
Antibodies |
|
Phase 3,Phase 2 |
|
|
|
28 |
|
Antibodies, Monoclonal |
|
Phase 3,Phase 2 |
|
|
|
29 |
|
Antidotes |
|
Phase 3 |
|
|
|
30 |
|
Antimetabolites |
|
Phase 3 |
|
|
|
31 |
|
Antimetabolites, Antineoplastic |
|
Phase 3 |
|
|
|
32 |
|
Bone Density Conservation Agents |
|
Phase 3 |
|
|
|
33 |
|
Calcium, Dietary |
|
Phase 3 |
|
|
|
34 |
|
Hematinics |
|
Phase 3 |
|
|
|
35 |
|
Immunoglobulins |
|
Phase 3,Phase 2 |
|
|
|
36 |
|
Immunosuppressive Agents |
|
Phase 3 |
|
|
|
37 |
|
Micronutrients |
|
Phase 3 |
|
|
|
38 |
|
Protective Agents |
|
Phase 3 |
|
|
|
39 |
|
Trace Elements |
|
Phase 3 |
|
|
|
40 |
|
Vitamin B Complex |
|
Phase 3 |
|
|
|
41 |
|
Vitamins |
|
Phase 3 |
|
|
|
42 |
|
Gastrointestinal Agents |
|
Phase 3 |
|
|
|
43 |
|
Antidiarrheals |
|
Phase 3 |
|
|
|
44 |
|
Cola |
Nutraceutical |
Phase 3,Phase 2 |
|
|
|
45 |
|
Folate |
Nutraceutical |
Phase 3 |
|
|
|
46 |
|
Vitamin B9 |
Nutraceutical |
Phase 3 |
|
|
|
47 |
|
Estradiol |
Approved, Investigational, Vet_approved |
Phase 2 |
|
50-28-2 |
5757
|
Synonyms:
(+)-3,17b-Estradiol
(17b)-Estra-1,3,5(10)-triene-3,17-diol
(17β)-estra-1,3,5(10)-triene-3,17-diol
.alpha.-Estradiol
.alpha.-Oestradiol
.beta.-Estradiol
.beta.-Oestradiol
[2,4,6,7-3H]-E2
[3H]]estradiol
[3H]-estradiol
13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol
17 beta-Estradiol
17.beta.-Estradiol
17-.BETA.-Estradiol
17.beta.-Oestradiol
17b-Estradiol
17-beta
17beta oestradiol
17-beta-estradiol
17beta-Estradiol
17beta-Oestradiol
17-beta-OH-estradiol
17b-Oestradiol
17E
17-E
17β-estra-1,3,5(10)-triene-3,17-diol
17β-estradiol
17β-oestradiol
1jgl
1qkt
1qku
2d06
3,17.beta.-Estradiol
3,17b-Dihydroxyestra-1,3,5(10)-triene
3,17b-Estradiol
3,17beta-Estradiol
3,17-beta-Estradiol
3,17-beta-Oestradiol
3,17-Epidihydroxyestratriene
50-28-2
73459-61-7
873662-39-6
AC-10460
AC1L1L2K
Aerodiol
Agofollin
Alora
Altrad
Amnestrogen
Aquadiol
Bardiol
b-Estradiol
B-Estradiol
beta-Estradiol
Beta-estradiol
BIDD:ER0125
BIDD:PXR0065
Bio-0812
Bio1_000403
Bio1_000892
Bio1_001381
Bio2_000363
Bio2_000843
Bio-E-Gel
bmse000642
BPBio1_000532
BSPBio_000482
BSPBio_001065
C00951
C18H24O2
CCRIS 280
CHEBI:16469
CHEMBL135
CID5757
cis-Estradiol
cis-Oestradiol
Climaderm
Climara
Climara (TN)
Climara Forte
cMAP_000005
CMC_11154
component of Menrium
Compudose
Compudose 200
Compudose 365
Corpagen
CPD000059126
CPD-352
D00105
D-3,17beta-Estradiol
DB00783
delta-Estradiol
delta-Oestradiol
Dermestril
Destradiol
D-Estradiol
Dihydrofollicular hormone
Dihydrofolliculin
Dihydromenformon
Dihydrotheelin
Dihydro-Theelin
Dihydroxyesterin
Dihydroxyestrin
Dihydroxyoestrin
Dimenformon
Diogyn
Diogynets
Divigel
Divigel (TN)
D-Oestradiol
E 2
E 8875
E(sub 2)
E0025
E1024_SIGMA
E1132_SIGMA
E2257_SIGMA
E2758_SIGMA
E8875_SIGMA
EINECS 200-023-8
Elestrin
Encore
Epiestriol 50
Esclim
Estra-1,3,5(10)-triene-3,17b-diol
Estrace
Estrace (TN)
Estraderm
Estraderm (TN)
Estraderm MX
Estraderm TTS
Estraderm TTS 100
Estraderm TTS 50
estradiol
Estradiol
Estradiol [USAN:INN]
Estradiol-17 beta
Estradiol-17.beta.
estradiol-17beta
Estradiol-17beta
Estradiol-17-beta
Estradiol-3,17beta
Estradiolo
Estradiolo [DCIT]
Estradiolum
Estradiolum [INN]
Estradot
Estraldine
Estrapak 50
Estrasorb
Estrasorb (TN)
|
Estreva
Estrifam
Estring
Estring (TN)
Estring vaginal ring
Estring Vaginal Ring
Estroclim
Estroclim 50
Estrodiolum
Estrofem 2
Estrofem Forte
Estrogel
Estrogel (TN)
Estrogel HBF
Estrovite
EU-0100503
Evamist
Evorel
Extrasorb
Femanest
Femestral
Femestrol
Femogen
Fempatch
Femtrace
Femtran
Follicyclin
Gelestra
Ginedisc
Ginosedol
Gynergon
Gynestrel
Gynodiol
Gynoestryl
GynPolar
HMS1362E07
HMS1569I04
HMS1792E07
HMS1990E07
HMS2051C17
HMS2090E18
HSDB 3589
IDI1_002118
Innofem
Innofem (TN)
KBio2_000405
KBio2_002269
KBio2_002973
KBio2_004837
KBio2_005541
KBio2_007405
KBio3_000769
KBio3_000770
KBio3_002749
KBioGR_000405
KBioGR_002269
KBioSS_000405
KBioSS_002270
Lamdiol
LMST02010001
Lopac0_000503
LS-137
Macrodiol
Macrol
Menest
Menorest
Microdiol
MLS000069494
MLS000758312
MLS001076331
MolPort-001-794-632
NCGC00091544-00
NCGC00091544-01
NCGC00091544-02
NCGC00091544-04
NCGC00091544-05
NCGC00091544-06
NCGC00091544-07
NCGC00091544-08
NCGC00091544-09
NCGC00091544-12
NCGC00179321-01
NCGC00179321-02
nchembio.168-comp3
nchembio.76-comp2
nchembio775-comp2
nchembio794-comp6
nchembio860-comp1
Nordicol
NSC9895
NSC-9895
Oesclim
Oestergon
Oestra-1,3,5(10)-triene-3,17b-diol
Oestradiol
Oestradiol Berco
Oestradiol R
Oestradiol-17.beta.
Oestradiol-17beta
Oestradiol-17-beta
Oestradiolum
Oestrogel
Oestroglandol
Oestrogynal
Ovahormon
Ovasterol
Ovastevol
Ovociclina
Ovocyclin
Ovocycline
Ovocylin
Perlatanol
Polyestradiol
Prestwick_207
Prestwick0_000441
Prestwick1_000441
Prestwick2_000441
Prestwick3_000441
Primofol
Profoliol
Profoliol B
progynon
Progynon
Progynon DH
Progynon-DH
S1709_Selleck
S-21400
SAM001247032
Sandrena 1
Sandrena Gel
Sisare Gel
SK-Estrogens
SL-1100
SMP1_000121
SMR000059126
SPBio_002421
Spectrum5_002055
Syndiol
Systen
Tradelia
Trial SAT
Trocosone
UNII-4TI98Z838E
Vagifem
Vagifem (TN)
Vivelle
Vivelle (TN)
VIVELLE-DOT
Zerella
Zesteem
Zesteen
Zumenon
|
|
48 |
|
Ethinyl Estradiol |
Approved |
Phase 2 |
|
57-63-6 |
5991
|
Synonyms:
17 alpha-ethinyestradiol
17 alpha-Ethinylestradiol
17 alpha-Ethynylestradiol
17 alpha-Ethynyloestradiol
17.alpha.-Ethinyl-17.beta.-estradiol
17.alpha.-Ethinylestradiol
17.alpha.-Ethynyl-17.beta.-oestradiol
17.alpha.-Ethynylestradiol
17.alpha.-Ethynylestradiol-l7.beta.
17.alpha.-Ethynyloestradiol
17.alpha.-Ethynyloestradiol-17.beta.
17a-Ethinyl-17b-estradiol
17a-Ethinylestradiol
17a-Ethynyl-17b-oestradiol
17a-Ethynylestradiol
17a-Ethynylestradiol-l7b
17a-Ethynyloestradiol
17a-Ethynyloestradiol-17b
17alpha-Ethinyl estradiol
17-alpha-Ethinyl-17-beta-estradiol
17alpha-Ethinylestradiol
17alpha-Ethinylestradiol-17beta
17-alpha-ethynyl estradiol
17-alpha-Ethynyl-17-beta-oestradiol
17alpha-Ethynylestradiol
17-alpha-Ethynylestradiol
17-alpha-Ethynylestradiol-17-beta
17alpha-Ethynyloestradiol
17alpha-Ethynyloestradiol-17beta
17-ethinyl-3,17-estradiol
17-Ethinyl-3,17-estradiol
17-ethinyl-3,17-oestradiol
17-Ethinyl-3,17-oestradiol
17-ethinylestradiol
17-Ethinylestradiol
17-Ethynylestradiol
17-Ethynylestradiol ram
17-Ethynyloestradiol
17α-ethynylestradiol
406932-93-2
46263_FLUKA
46263_RIEDEL
57-63-6
77538-56-8
AC1L1LK6
AC-2169
Aethinyloestradiolum
Aethinyoestradiol
Aethinyoestradiol [German]
AI3-52941
Alora
Amenoron
Amenorone
Anovlar
BIDD:ER0162
Bio-0610
BRN 2419975
C07534
CCRIS 286
Certostat
CHEBI:4903
Chee-O-Gen
Chee-O-Genf
CHEMBL691
CID5991
component of Demulen
component of Oracon
component of Ortrel
CPD000058319
Cyclosa
D004997
D00554
DB00977
Dicromil
Diognat-E
Diogyn E
Diogyn-E
Diprol
Dyloform
E4876_SIGMA
EE
EE(sub 2)
EE2
Effik Brand of Ethinyl Estradiol
EINECS 200-342-2
EO
Ertonyl
Esclim
Esteed
Estigyn
Estinyl
Estinyl (TN)
Eston-E
Estopherol
Estoral
Estoral (Orion)
Estoral (VAN)
Estoral [Orion]
Estoral {[Orion]}
Estorals
Estradiol, Ethinyl
Estradiol, Ethynyl
Estring
Estrogen
|
Ethidol
Ethinoral
Ethinyl E2
ethinyl estradiol
Ethinyl estradiol
Ethinyl estradiol (USP)
Ethinyl Estradiol [USP]
Ethinyl Estradiol Hemihydrate
Ethinyl Estradiol, (8 alpha)-Isomer
Ethinyl Oestradiol Effik
Ethinylestradiol
ETHINYLESTRADIOL
Ethinylestradiol (JP15/INN)
Ethinylestradiol [INN:BAN:JAN]
Ethinylestradiol Jenapharm
Ethinylestradiolum
Ethinylestradiolum [INN-Latin]
Ethinylestriol
Ethinyloestradiol
Ethinyloestradiol [Steroidal oestrogens]
Ethinyl-Oestradiol Effik
Ethinyl-oestranol
Ethy 11
Ethynyl estradiol
Ethynylestradiol
Ethynylestradiol, Ethinyl Estradiol
Ethynyloestradiol
Eticyclin
Eticyclol
Eticylol
Etinestrol
Etinestryl
Etinilestradiol
Etinilestradiol [INN-Spanish]
Etinilestradiolo
Etinilestradiolo [DCIT]
Etinoestryl
Etistradiol
Etivex
Feminone
Fempatch
Follicoral
Ginestrene
Gynodiol
Gynolett
Hemihydrate, Ethinyl Estradiol
HMS2051I19
HSDB 3587
Inestra
Innofem
Jenapharm Brand of Ethinyl Estradiol
Jenapharm, Ethinylestradiol
Kolpolyn
Linoral
LMST02010036
LS-231
Lynoral
Menolyn
Menostar
Microfollin
Microfollin Forte
MLS000028479
MLS000758274
MolPort-001-794-636
NCGC00091533-01
NCGC00091533-04
NCGC00091533-05
NCI60_000234
Neo-Estrone
Nogest-S
Novestrol
NSC10973
NSC-10973
Oradiol
Orestralyn
Orestrayln
Organon Brand of Ethinyl Estradiol
Ortho-Cyclen
Ovex
OVULEN-21
OVULEN-28
Palonyl
Perovex
Primogyn
Primogyn C
Primogyn M
Progynon C
Progynon M
Prosexol
PUBERTAL ETHINYL ESTRADIOL STUDY
S1625_Selleck
SAM001247008
Schering Brand of Ethinyl Estradiol
SGCUT00127
SMR000058319
Spanestrin
Thiuram E
Thiuranide
to_000048
UNII-423D2T571U
Vagifem
WLN: L E5 B666TTT&J E1 FQ F1UU1 OQ
Ylestrol
|
|
49 |
|
Medroxyprogesterone acetate |
Approved, Investigational |
Phase 2 |
|
71-58-9 |
|
Synonyms:
(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione
17-Acetoxy-6alpha-methylprogesterone
17-Acetoxy-6α-methylprogesterone
17alpha-Hydroxy-6alpha-methylprogesterone acetate
17α-hydroxy-6α-methylprogesterone acetate
6alpha-Methyl-17-acetoxy progesterone
6-alpha-Methyl-17-alpha-acetoxyprogesterone
6alpha-Methyl-17alpha-hydroxyprogesterone acetate
6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate
|
6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate
6α-Methyl-17-acetoxy progesterone
6α-Methyl-17α-hydroxyprogesterone acetate
Medroxyacetate progesterone
Medroxyprogesterone 17-acetate
Medroxyprogesterone acetate
Methylacetoxyprogesterone
Metigestrona
MPA
|
|
50 |
|
Norgestrel |
Approved |
Phase 2 |
|
6533-00-2 |
13109
|
Synonyms:
(-)-Norgestrel
)-Norgestrel
121714-72-5
13beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13-beta-Ethyl-17alpha-ethynyl-17beta-hydroxygon-4-en-3-one
13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE
13-Ehyl-17alpha-ethynyl-17-hydroxygon-4-en-3-one
13-Ethyl-17-alpha-ethynyl-17-beta-hydroxy-4-gonen-3-one
13-Ethyl-17alpha-ethynylgon-4-en-17beta-ol-3-one
13-Ethyl-17-alpha-ethynylgon-4-en-17-beta-ol-3-one
17alpha-Ethynyl-13beta-ethyl-3-oxo-4-estren-17beta-ol
17alpha-Ethynyl-13-ethyl-19-nortestosterone
17-alpha-Ethynyl-13-ethyl-19-nortestosterone
17alpha-ethynyl-17beta-hydroxy-18a-homoestr-4-en-3-one
17alpha-Ethynyl-17-hydroxy-18-methylestr-4-en-3-one
17alpha-Ethynyl-18-homo-19-nortestosterone
17alpha-Ethynyl-18-homo-19-nor-testosterone
17-ethynyl-17-hydroxy-18a-homoestr-4-en-3-one
17-Ethynyl-18-methyl-19-nortestosterone
18,19-Dinor-4-pregnen-20-yn-3-one
18-Methyl-17-alpha-ethynyl-19-nortestosterone
18-Methylnorethisterone
4222-79-1
6533-00-2
72-HOURS
797-62-6
797-63-7
AC1L211U
AC1Q6OEV
alpha-Norgestrel
BAY 86-5028
BAY86-5028
BIDD:PXR0194
Bio-0595
BPBio1_000932
BRD-K35189033-001-03-0
BRN 2391114
BSPBio_000846
C08149
C08153
Capronor
CCRIS 6525
CCRIS 9033
CHEBI:44593
CHEBI:6443
CHEMBL1389
CID13109
component of Lo/ovral
CPD000059117
D(−
d(-)-Norgestrel
D-(-)-Norgestrel
D00950
D00954
DB00367
DB00506
dl-13-beta-Ethyl-17-alpha-ethynyl-19-nortestosterone
dl-Norgestrel
D-Norgestrel
E-Gen-C
EINECS 212-349-8
EINECS 229-433-5
FH 122-A
Follistrel
HMS1570K08
HMS2051M08
HMS2090O06
HSDB 3595
HSDB 6483
Jadelle
Ld norgestrel
LD norgestrel
LD norgestrel [French]
Levlen
Levlen ED
Levonelle
Levonelle, D-Norgestrel, Levonova, Levonorgestrel
Levonorgestrel
Levonorgestrel (JAN/USP/INN)
Levonorgestrel [USAN:INN:BAN]
Levonorgestrel implants
Levonorgestrelum
Levonorgestrelum [INN-Latin]
Levonova
Levora-21
Levora-28
LMST02030119
LO/Ovral
Logynon ED
LS-62083
|
LS-62084
Methylnorethindrone
Microgest ED
Microgyn
Microgynon 21
Microgynon 28
Microgynon 30 ED
Microgynon CD
Microlut
Microlution
Microluton
Microval
Minivlar 30
Mirena
Mirena (TN)
MLS000069491
MLS000759484
MLS001074069
MolPort-002-510-453
Monofeme 28
Monovar
N2260_FLUKA
N2260_SIGMA
NCGC00159349-02
NCGC00159349-03
Neogest
Neogynon 21
Nordet
Nordette 21
Nordette 28
Norgeston
norgestrel
Norgestrel (JP15/USP/INN)
Norgestrel [Progestins]
Norgestrel [USAN:BAN:INN:JAN]
Norgestrel [USAN:INN:BAN:JAN]
Norgestrel-(-)-D
Norgestrelum
Norgestrelum [INN-Latin]
NorLevo
NORPLANT
Norplant (TN)
Norplant 2
Norplant II
Norplant System in Plastic Container
Norplant-2
NSC744007
Ovoplex 30-150
Ovral-Lo
Ovranette
Ovrette
Ovrette (TN)
Plan B
Postinor
Postinor-2
Prestwick_109
Prestwick0_000773
Prestwick1_000773
Prestwick2_000773
Prestwick3_000773
Preven
Rigevidon 21+7
S1727_Selleck
SAM001246694
SH 70850
SH 850
SMR000059117
SMR000653526
SOH-075
SPBio_002785
Stediril 30
Tetragynon
Triagynon
Triciclor
Trifeme 28
Trigoa
Tri-Levlen 21
Trinordiol 21
Trinordiol 28
Triphasil 21
Triphasil 28
Triquilar ED
Trivora
UNII-3J8Q1747Z2
UNII-5W7SIA7YZW
Wy 3707
Wy-3707
Wy-5104
ZINC03814395
|
|
Interventional clinical trials:
(show top 50)
(show all 76)
# |
Name |
Status |
NCT ID |
Phase |
Drugs |
1 |
Effect of Chemoprevention by Low-dose Aspirin of New or Recurrent Colorectal Adenomas in Patients With Lynch Syndrome |
Recruiting |
NCT02813824
|
Phase 3 |
Acetylsalicylic acid lysinate 300 mg;Placebo (for Aspirin 300);Acetylsalicylic acid lysinate 100 mg;Placebo 100 (for Aspirin 100) |
2 |
Combination Chemotherapy With or Without Atezolizumab in Treating Patients With Stage III Colon Cancer and Deficient DNA Mismatch Repair |
Recruiting |
NCT02912559
|
Phase 3 |
Atezolizumab;Fluorouracil;Leucovorin Calcium;Oxaliplatin |
3 |
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer |
Active, not recruiting |
NCT00217737
|
Phase 3 |
Fluorouracil;Leucovorin Calcium;Oxaliplatin |
4 |
Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers |
Not yet recruiting |
NCT02497820
|
Phase 3 |
Aspirin |
5 |
Phase III Trial Investigating the Potential Benefit of Adjvant Chemotherapy for Small Bowel Adenocarcinoma |
Not yet recruiting |
NCT02502370
|
Phase 3 |
observation alone;LV5FU2;FOLFOX |
6 |
Intrauterine Levonorgestrel and Observation or Observation Alone in Preventing Atypical Endometrial Hyperplasia and Endometrial Cancer in Women With Hereditary Non-Polyposis Colorectal Cancer or Lynch Syndrome |
Terminated |
NCT00566644
|
Phase 3 |
|
7 |
Use of Post Operative Loperamide in Colorectal Patients After Diverting Ileostomies |
Terminated |
NCT02263365
|
Phase 3 |
Loperamide |
8 |
CHROENDOHNPCC: Early Detection of Pre-cancer Lesions in Adults With Hereditary Nonpolyposis Colorectal Cancer Syndrome |
Completed |
NCT00224601
|
Phase 2 |
|
9 |
Hormone Therapy in Preventing Endometrial Cancer in Patients With a Genetic Risk For Hereditary Nonpolyposis Colon Cancer |
Completed |
NCT00033358
|
Phase 2 |
medroxyprogesterone;ethinyl estradiol;norgestrel |
10 |
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome |
Recruiting |
NCT03070574
|
Phase 2 |
Mesalamine 2400 MG;Mesalamine 1200 MG |
11 |
Talimogene Laherparepvec and Nivolumab in Treating Patients With Refractory Lymphomas or Advanced or Refractory Non-melanoma Skin Cancers |
Recruiting |
NCT02978625
|
Phase 2 |
|
12 |
Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI |
Active, not recruiting |
NCT01885702
|
Phase 1, Phase 2 |
|
13 |
Phase I-II Multiple-Dose Safety and Efficacy Study of a Selective Inhibitor of Cyclooxygenase - 2 (SC-58635) in Hereditary Non-Polyposis Colorectal Cancer (HNPCC) Patients and Carriers |
Completed |
NCT00001693
|
Phase 1 |
Celecoxib (SC-58635) |
14 |
Molecular Fluorescence Endoscopy in Patients With Familial Adenomatous Polyposis, Using Bevacizumab-IRDye800CW |
Completed |
NCT02113202
|
Phase 1 |
Bevacizumab-IRDye800CW |
15 |
Pembrolizumab in Treating Younger Patients With Recurrent, Progressive, or Refractory High-Grade Gliomas, Diffuse Intrinsic Pontine Gliomas, or Hypermutated Brain Tumors |
Recruiting |
NCT02359565
|
Phase 1 |
|
16 |
Naproxen in Preventing DNA Mismatch Repair Deficient Colorectal Cancer in Patients With Lynch Syndrome |
Active, not recruiting |
NCT02052908
|
Phase 1 |
Naproxen |
17 |
Hereditary Nonpolyposis Colorectal Cancer in Taiwan-Related Genetic Study and Clinical Applications |
Unknown status |
NCT00262171
|
|
|
18 |
Establishing Effective Screening Methods for Diagnosing Hereditary Nonpolypoisis Colorectal Cancer |
Unknown status |
NCT00516230
|
|
|
19 |
Implementation of a New Strategy to Identify HNPCC Patients |
Unknown status |
NCT00141466
|
|
|
20 |
Hypodontia and Ovarian Cancer |
Unknown status |
NCT01470235
|
|
|
21 |
Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting |
Completed |
NCT01582841
|
|
|
22 |
High Definition White-Light Colonoscopy vs. Chromoendoscopy for Surveillance of Lynch Syndrome. |
Completed |
NCT02951390
|
|
|
23 |
Chromoendoscopy to Decrease the Risk of Colorectal Neoplasia in Lynch Syndrome |
Completed |
NCT00905710
|
|
|
24 |
Capsule Endoscopy to Screen for Small Bowel Neoplasia in Lynch Syndrome |
Completed |
NCT00898768
|
Early Phase 1 |
|
25 |
Molecular Screening for Lynch Syndrome in Southern Denmark |
Completed |
NCT01216930
|
|
|
26 |
Uncertain Genetic Test Results for Lynch Syndrome |
Completed |
NCT01646112
|
|
|
27 |
Study of the Results of Education and Counseling for Persons Undergoing Genetic Testing for Hereditary Nonpolyposis Colon Cancer |
Completed |
NCT00004210
|
|
|
28 |
Psychosocial Aspects of Genetic Testing for Hereditary Nonpolyposis Colon Cancer |
Completed |
NCT00341575
|
|
|
29 |
Magnification Narrow Band Imaging Colonoscopy for Hereditary Non-Polyposis Colorectal Cancer Surveillance |
Completed |
NCT00313755
|
|
|
30 |
Screening for Gynecologic Cancers in Hereditary Nonpolyposis Colorectal Cancer (HNPCC) Patients |
Completed |
NCT00508846
|
|
|
31 |
I-Scan For Colon Polyp Detection In HNPCC |
Completed |
NCT01823471
|
|
|
32 |
Telemedicine vs. Face-to-Face Cancer Genetic Counseling |
Completed |
NCT00609505
|
|
|
33 |
Identifying Patients With Hereditary and Familial Colorectal Cancer by Using an Online Risk Tool |
Completed |
NCT02645084
|
|
|
34 |
Attitudes Towards Prophylactic Colectomy in Hereditary Non-polyposis Colorectal Cancer (HNPCC) Patients |
Completed |
NCT00582452
|
|
|
35 |
Educational CD-ROM Compared With Standard Informed Consent for Patients With Colorectal Cancer or a Family History of Colorectal Cancer |
Completed |
NCT00450424
|
|
|
36 |
Collecting Information From Patients and Family Members With Hereditary Colorectal Cancer Syndromes or Who Are at High Risk of Developing Colorectal Cancer |
Completed |
NCT00675636
|
|
|
37 |
Oligogenic Determinism of Colorectal Cancer |
Completed |
NCT01057953
|
|
|
38 |
Hereditary Colorectal and Associated Tumor Registry Study |
Completed |
NCT00633607
|
|
|
39 |
Narrow Band Imaging in the Prediction of Surveillance Intervals After Polypectomy in Community Practice: Ready for (a European) Prime Time |
Completed |
NCT02196402
|
|
|
40 |
Combined Colon and Endometrial Cancer Screening in Women With HNPCC |
Completed |
NCT00510796
|
|
|
41 |
Universal Screening for Lynch Syndrome in Women With Endometrial and Non-Serous Ovarian Cancer |
Recruiting |
NCT02494791
|
|
|
42 |
Registry for Women Who Are At Risk Or May Have Lynch Syndrome |
Recruiting |
NCT00508573
|
|
|
43 |
Study of Universal Screening for Lynch Syndrome in Chinese Patients of Endometrial Cancer |
Recruiting |
NCT03291106
|
|
|
44 |
Multi-Organ Screening Recommendations in Patients With Lynch Syndrome |
Recruiting |
NCT00582296
|
|
|
45 |
Cascade Genetic Testing for Hereditary Breast/Ovarian Cancer and Lynch Syndrome in Switzerland |
Recruiting |
NCT03124212
|
|
|
46 |
NBI Versus Indigo Carmine During Colonoscopy in Lynch Syndrome |
Recruiting |
NCT02570516
|
|
|
47 |
Metagenomic Evaluation of the Gut Microbiome in Patients With Lynch Syndrome and Other Hereditary Colonic Polyposis Syndromes |
Recruiting |
NCT02371135
|
|
|
48 |
The GEOLynch Cohort Study |
Recruiting |
NCT03303833
|
|
|
49 |
The Molecular Predisposition to Hereditary Nonpolyposis Colon Cancer (HNPCC) |
Recruiting |
NCT01447199
|
|
|
50 |
Risk-Reducing Surgeries for Hereditary Ovarian Cancer |
Recruiting |
NCT03294343
|
|
|
|